Hoping to collect the latest CSL dividend? Here's how

The next CSL dividend is fast approaching.

Key points
  • Unlike most other ASX 200 blue chips, CSL is not known for its dividends
  • But even so, this company has a strong record when it comes to increasing its payouts
  • So here's all you need to know about the next CSL dividend

Perhaps uniquely amongst the top shares of the S&P/ASX 200 Index (ASX: XJO), healthcare giant CSL Ltd (ASX: CSL) is not well known for its dividend payments.

That's because, unlike the big four banks, and the likes of BHP Group Ltd (ASX: BHP), Rio Tinto Limited (ASX: RIO), and Telstra Group Ltd (ASX: TLS), the CSL dividend yield doesn't often get above 1%.

Yet CSL still has a long and proud history of paying dividends to its shareholders. In fact, it has upped its dividend quite substantially over the past few years. Back in 2019, investors enjoyed $2.66 in annual dividends per share. But in 2022, this had ratcheted up to $3.18 per share.

This trend seems to be continuing in 2023. CSL's next interim dividend, and its first for the year, is due on 5 April next month and will come in at US$1.07 per share, unfranked. That's a decent 2.88% increase over 2022's interim dividend of US$1.04 cents per share.

an older couple look happy as they sit at a laptop computer in their home.

Image source: Getty Images

You'd better be quick if you want the next CSL dividend

But if you wish to collect this latest dividend from the blood plasma and vaccine company, you'd better be quick. That's because CSL is scheduled to trade ex-dividend for this next payment in just two days' time. Yes, CSL will 'go ex-div' for its next interim dividend on 9 March – this Thursday.

When a company trades ex-dividend, it cuts off any new investors from receiving its latest dividend payment. So anyone who owns CSL shares by the close of tomorrow's trading session will receive the company's upcoming dividend payment. But anyone who buys CSL shares from Thursday onwards will not.

Because of this, we can expect to see a bit of a drop in the CSL share price on Thursday morning. This will reflect the fact that CSL shares will become slightly less viable on Thursday, seeing as the shares will no longer come with the right to receive this latest dividend.

This is what typically happens when an ASX divided share passes its ex-dividend date.

So, as you might have gathered, CSL denominates its dividend payments in US dollars.

The raw amount of US$1.07 per share has been fixed, but ASX investors will only find out exactly how much is coming their way in Australian dollar terms on 10 March, this Friday. On today's exchange rates though, it will be around $1.59 per share.

Then, it's less than a month until dividend payday on 5 April.

At today's pricing, CSL shares are up 4.31% in 2023 so far:

At this share price, CSL shares now have a dividend yield of 0.96%.

Motley Fool contributor Sebastian Bowen has positions in Telstra Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has positions in and has recommended Telstra Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Numerous Australian dollar notes laid out.
Healthcare Shares

I'd buy 6,462 shares of this ASX stock to aim for $200 a month of passive income

This business can provide very healthy dividends.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Healthcare Shares

UBS thinks Telix Pharmaceuticals shares will go how high?

Good news out of the US has led to a share price target upgrade.

Read more »

Scientist taking down notes from a tablet, with two other scientists working in the background.
Healthcare Shares

Healius vs Australian Clinical Labs: Which ASX pathology share wins?

Healius and Australian Clinical Labs are both top pathology providers, but one stands out for profits, dividends, and recent momentum.

Read more »

Doctor looks at a graph on a tablet.
Healthcare Shares

Ramsay Health Care vs Sonic Healthcare: Which healthcare stock is better value?

Which offers better value — Ramsay Health Care or Sonic Healthcare? I compare their fundamentals, dividends, momentum and reveal my…

Read more »

A doctor looks unsure.
Healthcare Shares

CSL shares jump 93%: Is the ASX biotech stock a buy, sell or hold for October?

Can the CSL share price rebound keep going?

Read more »

Two doctors having a discussion about a patient diagnosis, holding digital tablet.
Healthcare Shares

Are CSL shares a buy after its big news?

I look at what CSL’s latest drug development deal could mean for the healthcare giant’s long-term growth.

Read more »

A female scientist in a laboratory setting using a tablet to review data, with a male scientist working in the background.
Healthcare Shares

ResMed vs Fisher & Paykel Healthcare: Which is better value?

How do ResMed and Fisher & Paykel compare on value, income, and share price momentum? Here’s my verdict on which…

Read more »

Happy doctor using her laptop.
Healthcare Shares

CSL unveils exclusive Alentis deal to advance rare disease treatments

CSL unveils a major partnership for rare disease drug development, enhancing its global nephrology strategy.

Read more »